Nicole E Chambers
Affiliations: | 2021-2024 | Pharmacology & Therapeutics | University of Florida |
Area:
Parkinson's disease, dystonia, movement disorders, electrophysiology, behavioral neuroscience, systems neuroscienceGoogle:
"https://scholar.google.com/citations?user=QTwrekoAAAAJ&hl=en"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Howard Casey Cromwell | research assistant | 2012-2012 | Bowling Green State University | |
| (Undergraduate Research Assistant January 2012-August 2012) | ||||
| Andrew Mienaltowski | grad student | 2012-2015 | Western Kentucky University | |
| Christopher R. Bishop | grad student | 2014-2020 | SUNY Binghamton | |
| Mark Moehle | post-doc | 2021-2024 | University of Florida | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Millett M, Heuberger A, Castosa EM, et al. (2024) α Regulates Biochemical Signaling in Neurons Associated with Movement Control and Initiation. Biorxiv : the Preprint Server For Biology |
| Centner A, Del Priore I, Chambers N, et al. (2024) Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study. The European Journal of Neuroscience |
| Chambers NE, Millett M, Moehle MS. (2023) The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders. Biochemical Society Transactions. 51: 691-702 |
| Chambers NE, Coyle M, Sergio J, et al. (2021) Effects of Pedunculopontine Nucleus Cholinergic Lesion on Gait and Dyskinesia in Hemiparkinsonian Rats. The European Journal of Neuroscience |
| Chambers NE, Lanza K, Bishop C. (2019) Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease. Frontiers in Pharmacology. 10: 1494 |
| Lanza K, Chemakin K, Lefkowitz S, et al. (2019) Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat. Psychopharmacology |
| Chambers NE, Meadows SM, Taylor A, et al. (2019) Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat. Neuroscience |
| Sellnow RC, Newman JH, Chambers N, et al. (2019) Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia. Acta Neuropathologica Communications. 7: 8 |
| Meadows SM, Conti MM, Gross L, et al. (2018) Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats. Movement Disorders : Official Journal of the Movement Disorder Society. 33: 1740-1749 |
| Lanza K, Meadows SM, Chambers NE, et al. (2018) Behavioral and cellular dopamine D and D receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia. Neuropharmacology |